Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Zack's Senior Biotech Analyst Discusses International Stem Cell Corporation

Jason Napodano, Zack's Investment Research Senior Biotech Analyst, recently initiated coverage on International Stem Cell Corporation (OTCQB:ISCO).  Brett Johnson with OneMed Radio sat down with Jason for an interview about ISCO. Although the views and opinions are Mr. Napando's own and not those of ISCO, we thought you would be interested in his insights about our company. 

Source :